BIOMAT Database Logo BIOMAT Database Logo

Hypersensitivity to Covid-19 Vaccine Confirmed by a Positive Skin Test Result: A Case Report. 2021

S Pérez-Codesido, and A Rosado, and M D Alonso-Díaz-de-Durana, and T Alfaya Arias, and A González-Moreno, and M A Tejedor Alonso
Allergy Unit, Hospital Universitario Fundación Alcorcón, Alcorcón (Madrid), Spain.

UI MeSH Term Description Entries
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000090982 BNT162 Vaccine mRNA vaccine against SARS-CoV-2 developed by Pfizer and BioNTech. Abdavomeran,BNT-162A1,BNT-162B1,BNT-162B2,BNT-162C2,BNT162A1,BNT162B1,BNT162B2,BNT162C2,COVID-19 Vaccine Pfizer-BioNTech,Comirnaty,Pfizer Covid-19 Vaccine,Pidacmeran,Tozinameran,BNT 162A1,BNT 162B1,BNT 162B2,BNT 162C2,COVID 19 Vaccine Pfizer BioNTech,Covid-19 Vaccine, Pfizer,Pfizer Covid 19 Vaccine,Pfizer-BioNTech, COVID-19 Vaccine,Vaccine Pfizer-BioNTech, COVID-19,Vaccine, BNT162,Vaccine, Pfizer Covid-19
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin

Related Publications

S Pérez-Codesido, and A Rosado, and M D Alonso-Díaz-de-Durana, and T Alfaya Arias, and A González-Moreno, and M A Tejedor Alonso
Delayed-type hypersensitivity skin reaction to Covid-19 vaccine.
October 2021, Journal of family medicine and primary care,
S Pérez-Codesido, and A Rosado, and M D Alonso-Díaz-de-Durana, and T Alfaya Arias, and A González-Moreno, and M A Tejedor Alonso
Desensitization to Pertuzumab With a Positive Skin Test Result in a Mixed-Phenotype Hypersensitivity Reaction.
July 2022, Journal of investigational allergology & clinical immunology,
S Pérez-Codesido, and A Rosado, and M D Alonso-Díaz-de-Durana, and T Alfaya Arias, and A González-Moreno, and M A Tejedor Alonso
Social Behaviors Associated With a Positive COVID-19 Test Result.
February 2021, Cureus,
S Pérez-Codesido, and A Rosado, and M D Alonso-Díaz-de-Durana, and T Alfaya Arias, and A González-Moreno, and M A Tejedor Alonso
Mental distress in a clinical nurse due to a false-positive COVID-19 antibody test result during the COVID-19 epidemic in Japan: A case report.
May 2021, Clinical case reports,
S Pérez-Codesido, and A Rosado, and M D Alonso-Díaz-de-Durana, and T Alfaya Arias, and A González-Moreno, and M A Tejedor Alonso
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity.
November 2022, Allergy,
S Pérez-Codesido, and A Rosado, and M D Alonso-Díaz-de-Durana, and T Alfaya Arias, and A González-Moreno, and M A Tejedor Alonso
A case of hypersensitivity reaction to alcohol confirmed by oral provocation test.
October 2019, Journal of the European Academy of Dermatology and Venereology : JEADV,
S Pérez-Codesido, and A Rosado, and M D Alonso-Díaz-de-Durana, and T Alfaya Arias, and A González-Moreno, and M A Tejedor Alonso
Terbinafine-induced acute generalized exanthematous pustulosis confirmed by a positive patch-test result.
October 1997, Journal of the American Academy of Dermatology,
S Pérez-Codesido, and A Rosado, and M D Alonso-Díaz-de-Durana, and T Alfaya Arias, and A González-Moreno, and M A Tejedor Alonso
Interpreting a covid-19 test result.
May 2020, BMJ (Clinical research ed.),
S Pérez-Codesido, and A Rosado, and M D Alonso-Díaz-de-Durana, and T Alfaya Arias, and A González-Moreno, and M A Tejedor Alonso
Delayed hypersensitivity to ribavirin confirmed by provocation test.
January 2014, Journal of investigational allergology & clinical immunology,
S Pérez-Codesido, and A Rosado, and M D Alonso-Díaz-de-Durana, and T Alfaya Arias, and A González-Moreno, and M A Tejedor Alonso
Skin reaction to COVID-19 vaccine: A report of 4 cases.
September 2022, Dermatology reports,
Copied contents to your clipboard!